Skip to content

L01EJ Janus-associated kinase (JAK) inhibitors

ATC class of level 4 – chemical subgroup

This page lists the patient medication information or the product monograph for 3 drugs in this drug class and its subclasses.

3 prescription (Rx)

Place in the ATC system

L Antineoplastic and immunomodulating agents 1,069 drugs
1. L01 Antineoplastic agents 616 drugs
  1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
    1. L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
      1. L01EJ01 Ruxolitinib 1 drug
      2. L01EJ02 Fedratinib 1 drug
      3. L01EJ04 Momelotinib 1 drug

Active ingredients of the class

Fedratinib (fedratinib hydrochloride) 1 drug
Momelotinib (momelotinib dihydrochloride) 1 drug
Ruxolitinib (ruxolitinib phosphate) 1 drug

Drugs in the class and its subclasses

Drug	Rx or OTC
Inrebic (L01EJ02 Fedratinib)	prescription (Rx)
Jakavi PM (L01EJ01 Ruxolitinib)	prescription (Rx)
Ojjaara PM (L01EJ04 Momelotinib)	prescription (Rx)

Other classes of the same level

L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
L01EX Other protein kinase inhibitors 30 drugs

Other names of the drug class

English (United Kingdom): L01EJ Janus-associated kinase (JAK) inhibitors
German: L01EJ Janus-assoziierte Kinase (JAK)-Inhibitoren
German (Austria): L01EJ Janus-assoziierte Kinase (JAK)-Inhibitoren
Italian: L01EJ Inibitori della chinasi Janus associata
Turkish: L01EJ Janus ile ilişkili kinaz (JAK) inhibitörleri
Czech: L01EJ Inhibitory janus kináz (JAK)
German (Switzerland): L01EJ Janus-assoziierte Kinase (JAK)-Inhibitoren
Italian (Switzerland): L01EJ Inibitori della chinasi Janus associata
Dutch: L01EJ Januskinase(JAK)-remmers

Sources

Patient medication information and product monographs: Health Canada, Drug Product Database
Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
World Health Organization (WHO): ATC/DDD system, class L01EJ

Ask your doctor or pharmacist for advice.